Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dexmedetomidine vs. Remifentanil for Sedation During AFI

This study has been completed.
Hospira, Inc.
Information provided by (Responsible Party):
Carin A. Hagberg, The University of Texas Health Science Center, Houston Identifier:
First received: July 5, 2006
Last updated: March 22, 2016
Last verified: March 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2007
  Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)